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ABSTRACT
Cell-cell fusion contributes to cell differentiation and de-
velopmental processes. We have previously showed that
activation of Wnt/b-catenin enhances somatic cell reprog-
raming after polyethylene glycol (PEG)-mediated fusion.
Here, we show that neural stem cells and ESCs can fuse
spontaneously in cocultures, although with very low efﬁ-
ciency (about 2%), as the hybrids undergo apoptosis. In
contrast, when Wnt/b-catenin signaling is activated in
ESCs and leads to accumulation of low amounts of b-cate-
nin in the nucleus, activated ESCs can reprogram somatic
cells with very high efﬁciency after spontaneous fusion.
Furthermore, we also show that different levels of b-cate-
nin accumulation in the ESC nuclei can modulate cell pro-
liferation, although in our experimental setting, cell
proliferation does not modulate the reprograming efﬁ-
ciency per se. Overall, the present study provides evidence
that spontaneous fusion occurs, while the survival of the
reprogramed clones is strictly dependent on induction of a
Wnt-mediated reprograming pathway. STEM CELLS
2010;28:1940–1949
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INTRODUCTION
Cell-cell fusion regulates many developmental processes. Fer-
tilization, muscle and bone development, and syncytiotropho-
blast formation are all known examples of cell-cell fusions
[1]. However, cell-cell fusion might also regulate cell fate and
cell differentiation. Neural stem cells (NSCs) and bone mar-
row cells (BMCs) have indeed been shown to fuse sponta-
nously with embryonic stem cells (ESCs), even if this occurs
at a very low efﬁciency [2, 3]. The few hybrid clones selected
were shown to have a stem cell-like phenotype. The stem cell
features of ESCs were dominant over the somatic cell traits
and allowed the reprograming of the somatic cell nucleus.
Thus, cell-cell fusion is a way to force the fate of a cell, and
in the case of fusion with ESCs, this mechanism induces cel-
lular reprograming, that is, dedifferentiation of somatic cells
[4].
We have recently shown that fusion-mediated reprogram-
ing of a somatic cell is greatly enhanced by time-dependent
activation of the Wnt/b-catenin signaling pathway. After Wnt
binding to its receptors or inhibition of glycogen synthase ki-
nase-3 (GSK3), as a component of the destruction complex,
b-catenin is stabilized and translocates into the nucleus, where
it activates several target genes. ESCs treated for 24 hours
with Wnt3a or with the GSK3 inhibitor, 6-bromoindirubin-30-
oxime (BIO), can reprogram somatic cells after polyethylene
glycol (PEG)-mediated fusion [5].
In vivo cell-cell fusion has also been seen after bone mar-
row (BM) transplantation. BM-derived cells fuse at low efﬁ-
ciency with hepatocytes, kidney cells [6, 7], muscle cells [8,
9], and even Purkinje cells in the cerebellum [10–12]. Chronic
inﬂammation increases the fusion efﬁciency in the brain.
However, even if in vivo fusion has been described in many
reports, its efﬁciency appears to be extremely low, which has
also resulted in some skepticism around the physiology of
some studies [4]. It should also be noted that if cell-cell
fusion is a mechanism that regulates cell fate and cell differ-
entiation, then this mechanism must be ﬁnely tuned; poten-
tially, the destiny of the majority of hybrids that are spontane-
ously formed is to undergo cell death via apoptosis. Indeed,
ESCs have an apoptotic machinery and an antiapoptotic
defense program. When subjected to prolonged hypoxia or
oxidative stress induced with H2O2 or citrinin, they embark
on apoptosis [13–15].
Here, we show that ESCs fuse with NSCs spontaneously
at low efﬁciency (about 2%) and that the resulting fusion
hybrids will undergo apoptosis unless the Wnt/b-catenin path-
way is activated, whereupon they undergo reprograming and
cell proliferation. Only a low level of b-catenin in the nucleus
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cells after their spontaneous fusion. Our data demonstrate that
the Wnt/b-catenin signaling pathway is the cell-fate switch
that promotes reprograming of spontaneous hybrids against
their apoptosis-mediated cell death.
MATERIALS AND METHODS
Cells
Neural stem (NS)-Oct4-puro cells were isolated from HP165
mice and they carry the regulatory sequences of the mouse Oct4
gene driving green ﬂuorescent protein (GFP) and puromycin-re-
sistance genes. The NS-Oct4-puro cells were a gift from Dr. A.
Smith (Wellcome Trust Centre for Stem Cell Research, Univer-
sity of Cambridge, Cambridge, U.K.) and were cultured as previ-
ously described [16]. Hygromycin-resistant mouse embryonic
ﬁbroblasts (MEFs) were purchased at passage three (Millipore,
Billerica, MA, USA, http://www.millipore.com). Embryonic stem
(ES)-neo cells were derived from E14Tg2a and transduced with
the lentiviral pHRcPPT-PGK-Neomycin vector. ESCs were cul-
tured on gelatin in knockout Dulbecco’s modiﬁed Eagle’s me-
dium supplemented with 20% fetal bovine serum (Hyclone, South
Logan, UT, USA, http://www.thermoscientiﬁc.com), 1  nones-
sential amino acids, 1  GlutaMax, 1  2-mercaptoethanol, and
1,000 U/ml leukemia inhibitory factor (LIF) ESGRO (Chemicon,
Billerica, MA, USA, http://www.millipore.com).
Cell Hybrids
ESC þ NSC and ESC þ MEF cocultures: 1   10
6 ESCs were
plated onto preplated 1   10
6 NSCs or MEFs, ﬁrst for 2 hours in
NSC or MEF medium, respectively, and then for 2 hours in ESC
medium. The cells were then trypsinized, and plated at 20% into
gelatinþlaminin-treated p100 dishes in ESC medium without or
with 1 lM BIO (Calbiochem, Darmstadt, Germany, http://
www.emdchemicals.com/life-science-research/calbiochem), for
different times. After 72 hours, puromycin or hygromycin plus
neomycin were added to the ES medium for hybrid selection.
For cell treatment with carbobenzoxy-valyl-alanyl-aspartyl-
[O-methyl]- ﬂuoromethylketone (z-VAD)-FMK (R&D Systems,
Minneapolis, MN, USA, http://www.rndsystems.com/) the inhibi-
tor was dissolved in dimethylsulphoxide and incubated with the
cells (20 lM) for 36 hours. Seventy-two hours after coculture,
puromycin was added to the ES medium for hybrid selection.
Plasmid Construction and Stable
ES Clone Generation
Mouse b-catenin mutated at serine 33 was a gift from Dr. de la
Luna (Centre for Genomic Regulation, Barcelona, Spain) and it
was subcloned into the empty pCAG-C1 vector, which contained,
in sequence order: CAG promoter, a multicloning site, internal
ribosome entry site, neomycin-resistance gene, and polyA. Stable
ESC lines expressing b-catenin were isolated after nucleofection
(Amaxa, Basel, Switzerland, http://lonza.com/group/en/company.
html) of this construct, and drug selection was performed with
250 lg/ml neomycin, as previously described.
Transient Transfections and Luciferase Activity
ESCs were cotransfected by nucleofection (Amaxa) with the Top-
ﬂash reporter construct driving ﬁreﬂy luciferase cDNA [5] and
pRL-CMV driving constitutive expression of Renilla cDNA for
normalization. The cells were lysed with 1  passive reporter
lysis buffer. The ﬁreﬂy and Renilla reporter activities were meas-
ured using a 96-well-based luminometer, with detection according
to manufacturer instructions (Promega Dual-Light system, Madi-
son, WI, USA, http://www.promega.com).
Western Blotting
Western blotting was performed as previously described [17].
The primary antibodies used were: anti-phospho-c-Myc (Thr58/
Ser62; #9401 Cell Signaling Technologies, Danvers, MA, USA,
http://www.cellsignal.com/); anti-c-Myc (N-262) sc-764 (Santa
Cruz Biotechnology, Santa Cruz, CA, USA, http://www.scbt.com/);
and anti-b-tubulin, clone D66, T0198 (Sigma-Aldich, St. Louis,
MO, USA, http://www.sigmaaldrich.com/).
Semiquantitative RT-PCR Analysis
For reverse transcriptase PCR (RT-PCR), total RNA was
extracted from ESCs and from embryoid bodies (200 embryoid
bodies for each clone and for each differentiation time point)
using RNeasy kits (Qiagen, Washington, DC, USA, http://
www.qiagen.com/), and the cDNA was generated using super-
script III (Invitrogen, Carlsbad, CA, USA, http://www.invitrogen.
com/site/us/en/home.html). The primers used were:
Oct4: forward, GGCGTTCTCTTTGGAAAGGTGTTC; reverse,
CTCGAACCACATCCTTCTCT;
Nanog: forward, AGGGTCTGCTACTGAGATGCTCTG;
reverse, CAACCACTGGTTTTTCTGCCACCG;
Rex1: forward, GCCCTCGACAGACTGACCCTAA; reverse,
CTTCCTCAGGGCGGTTTTACCC;
Fgf4: forward, GACTACCTGCTGGGCCTCAA; reverse,
CGACACTCGGTTCCCCTTCT;
Olig2: forward, GCGTGGGTATCAGAAGCACT; reverse,
CCAGTCGGGTAAGAAACCAA;
Blbp: forward, GGGTAAGACCCGAGTTCCTC; reverse,
ATCACCACTTTGCCACCTTC;
Brachyury: forward, TGCTGCCTGTGAGTCATA; reverse,
ACAAGAGGCTGTAGAACATG;
Nkx2.5: forward, GCTCTCCTGCTTTCCCAGC; reverse,
CTCCCATCCCTACTGCCTTCTGCAGC;
Alpha-fetoprotein (AFP): forward, TCCCTCATCCTCCTGCTA;
reverse, GCACAT TCTTCTCCGTCAC;
glyceraldehyde 3-phosphate dehydrogenase (GAPDH): forward,
ACTCCCACTCTTCCACCTTC; reverse, TCTTGCTCAGTGTCCT
TGC.
Bisulphite Genomic Sequencing
Bisulphite treatment was performed using Epitect Bisulphite kits
(Qiagen), according to the manufacturer recommendations. The
ampliﬁed products were cloned into pCR2.1-TOPO (Invitrogen).
Ten randomly selected clones were sequenced with the M13 for-
ward and M13 reverse primers for each gene, as follows:
MeNanog: forward, GATTTTGTAGGTGGGATTAATTGT-
GAATTT; reverse, ACCAAAAAAACCCACACTCATATCAA
TATA;
MeOct4: forward, GGTTTTTTAGAGGATGGTTGAGTG;
reverse, TCCAACCCTACTAACCCATCACC.
FACS Analysis
Twenty-four hours before fusion, the NS-Oct4-puro cells were
stained with Vybrant DiO (5 ll/ml; Invitrogen) in NSC medium
for 20 minutes at 37 C. The cells were thoroughly rinsed (three
times) with phosphate-buffered saline (PBS) before being trypsi-
nized and replated in t25 ﬂasks. The day after, the untreated and
treated ESCs (BIO or Wnt3a, up to 48 hours) were stained with
Vybrant DiD (5 ll/ml; Invitrogen) in ESC medium for 20
minutes at 37 C, washed, trypsinized, counted, and plated on NS-
Oct4-puro cells. After 4 hours of coculture, the total cells were
trypsinized and divided: 80% were used for ﬂuorescence acti-
vated cell sorting (FACS) analysis and 20% were plated for
reprograming analysis. The cells used for FACS analysis were
centrifuged and resuspended in PBS with 0.1% bovine serum.
FACS analyses were performed using a BD Biosciences FACSA-
ria cytometer (Franklin Lakes, New Jersey, USA, http://
www.bdbiosciences.com/home.jsp).
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The differentiation medium for the production of embryoid
bodies consisted of ES medium without LIF. The cells were har-
vested by trypsinization, counted, and propagated in hanging
drops (400 single ES cells/30 ll initial drop) for 2 days, before
being transferred to 10-cm
2-bacterial dishes. On day 5, the
embryoid bodies were transferred onto gelatinized p100 dishes.
Teratoma Production
Cells were trypsinized into single-cell suspensions and resus-
pended in PBS to a concentration of 1.5   10
7 cells/ml. These
cells were injected subcutaneously into the hind limbs of Fox
Chase severe combined immunodeﬁciency (SCID) mice (in 200
ll) using a 25-gauge needle. Teratomas were collected after 4
weeks, and they were ﬁxed, embedded, sectioned, and H&E
stained.
Quantitative RT-PCR
RNA isolation and reverse transcription were carried out as
described for semiquantitative RT-PCR. The template for each
PCR reaction was the cDNA obtained from 16 ng total RNA in a
25-ll reaction volume. Platinum SYBR green qPCix-UDG (Invi-
trogen) was used with an ABprism 7000 real-time PCR machine,
according to the manufacturer recommendations. The primers
used were:
p16RT: forward, GTGTGCATGACGTGCGGG; reverse,
GCAGTTCGAATCTGCACCGTAG; p19RT: forward, GCTCTG
GCTTTCGTGAACATG; reverse, TCGAATCTGCACGCTAGT
TGAG.
Cell Proliferation Analysis Using 5-(and 6-)
Carboxyﬂuorescein Diacetate Succinimidyl
Ester Staining
ES cells were labeled with 5-(and 6-)carboxyﬂuorescein diacetate
succinimidyl ester (CFSE; Molecular Probes, Carlsbad, CA, USA,
http://www.invitrogen.com/site/us/en/home.html) at a concentra-
tion of 5 lM, for 15 minutes in PBS with 1% BSA at 37 C. The
cells were washed several times with serum-containing medium,
and then tested for cell viability using Trypan blue exclusion.
Following culture for 12–24 hours with complete medium, ﬂow
cytometry was performed with a FACS Aria (BD Biosciences)
and CFSE was analyzed in Modﬁt software.
Cell Proliferation Analysis Using 5-bromo-2-deoxy-
uridine (BrdU) Assay
Cells (1   10
4) were treated with or without puriﬁed Wnt3a (100
ng/ml) or BIO (1 lM) up to 48 hours. Quantitation of BrdU posi-
tive cells (3 hours of BrdU treatment), which indicates the num-
ber of cells that enter S-phase, was through the BrdU Cell Prolif-
eration Assay (Chemicon), according to the manufacturer
protocol.
Cell Viability Assay
Cells (1   10
4) were treated with or without H2O2 (250 lM) and
citrinin (60 lM) at 37 C for 24 hours. Quantitation of ATP,
which indicates the presence of metabolically active cells, was
through the CellTiter-Glo Luminiscent Cell Viability Assay
(Promega), according to the manufacturer protocol.
Cell Apoptosis Assay
Cells (1   10
4) were treated without or with H2O2 (250 lM) and
citrinin (60 lM) at 37 C for 24 hours. Oligonucleosomal DNA
fragmentations (a hallmark of apoptosis) were measured using
Cell Death Detection ELISA
plus kits, according to the manufac-
turer protocol (Roche Molecular Biochemicals, Basel, Switzer-
land, http://www.roche.com/index.htm). Spectrophotometric data
were obtained at 405 nm using an ELISA reader.
RESULTS
Activation of Wnt/b-Catenin Pathway Does Not
Protect ESCs from Entering Apoptosis
Activation of Wnt/b-catenin signaling controls ESC self-
renewal and enhances somatic cell reprograming [5, 18, 19].
Wnt signaling can be activated by the inhibition of GSK3
with BIO [20], which results in the nuclear accumulation of
b-catenin. Low levels of nuclear b-catenin accumulation can
be obtained by culturing ESCs in 1 lM BIO-containing me-
dium [5]. The ESCs were thus cultured in BIO for 12, 24,
and 48 hours, and then harvested to analyze their viability
and apoptotic phenotype. The different BIO treatments did
not modify the cell viability or promote a decrease or increase
in apoptosis over the untreated ESCs (Fig. 1A, 1B; compare
white bars). In contrast, ESCs treated with 250 lMH 2O2 or
with 60 lM citrinin (Fig. 1A, 1B; compare No BIO white and
black bars and data not shown) showed increased apoptosis
and decreased viability, as previously shown [13–15]. Interest-
ingly, when the ESCs were precultured with BIO for different
times and then treated with H2O2 or citrinin, BIO did not pro-
tect the cells from apoptosis or increase their viability, ruling
out a role for Wnt signaling in an anti-apoptotic pathway
(Fig. 1A, 1B and data not shown).
To conﬁrm that the Wnt canonical pathway did not acti-
vate transcription of antiapoptotic genes or of genes enhanc-
ing cell survival, we analyzed a variety of ES clones express-
ing different levels of b-catenin [5]. The activity of b-catenin
in the different clones was evaluated by testing the expression
of the reporter FOPﬂash and TOPﬂash genes (luciferase gene
under the control of the transcription factor/lymphoid
enhancer factor (TCF/LEF)-containing promoter [18]; support-
ing information Fig. S1). Although the clones expressed dif-
ferent levels of b-catenin, they showed comparable levels of
apoptosis, with respect to wild-type ESCs. This held true for
both untreated and H2O2/ citrinin-treated cells (Fig. 1C and
data not shown). The cell viability of all of the b-catenin ESC
clones or of the wild type (WT) cells treated with H2O2 or
citrinin decreased with respect to the untreated clones (Fig.
1C, 1D and data not shown). Thus, both high and low levels
of nuclear b-catenin accumulation did not protect the cells
from apoptosis or increase their survival. Of note, there was a
decrease in cell viability in the untreated clones expressing
medium or high levels of b-catenin (the a-8 and C-2 clones;
Fig. 1D; compare white bars). This was probably due to
reduced cell proliferation (measured by the CFSE assay) and
to upregulation of the cyclin inhibitor genes p16
Ink4a and
p19
Arf (Fig. 1E, 1F).
All in all, these data show that in ESCs, the Wnt/b-cate-
nin pathway does not regulate and/or modulate either the apo-
ptotic machinery or cell viability.
Activation of the Wnt/b-Catenin Pathway Enhances
Reprograming of Hybrids Spontaneously Formed
Between ESCs and Somatic Cells
ESCs were shown to fuse spontaneously (without PEG) with
NSCs and BMCs, although with a very low efﬁciency that
gives rise to few reprogramed clones [2, 3]. Thus, we
hypothesized that the majority of hybrids did not undergo
reprograming but instead underwent apoptosis. Here, we
investigated whether the activation of the Wnt/b-catenin sig-
naling pathway enhances reprograming of spontaneously
fused cells, with the consequence that a high number of
clones can be selected.
1942 Spontaneous Cell Fusion-Mediated ReprogramingWe then evaluated whether the pretreatment of ESCs with
BIO or Wnt3a, and their subsequent coculture with NS-Oct4-
puro/GFP cells (called NS-Oct4-puro cells) allowed the
reprograming of spontaneously fused cells. NS-Oct4-puro
cells expressed the PuroR gene and GFP under the control of
the Oct4 promoter, which is only active in pluripotent cells.
ESCs were incubated with the cell membrane dye DiD (red
dye), pretreated with 1 lM BIO or 100 ng/ml Wnt3a for 12,
24, and 48 hours, and then seeded into dishes where DiO
(green)-labeled NS-Oct4-puro cells had previously been
plated. These cells were cocultured for 4 hours, to allow the
formation of fusion hybrids. The hybrids were then trypsi-
nized and the cell suspension was divided into two parts.
Eighty percentage of the cells were analyzed by FACS, and
the remaining 20% were replated, to select for the reprog-
ramed clones. The hybrids were selected in ESC medium sup-
plemented with puromycin (Fig. 2A). Under these culture
conditions, only reprogramed hybrids can survive, proliferate,
and grow [5, 21]. The resistant colonies were stained for the
expression of alkaline phosphatase (AP), an ESC marker, and
counted. These cells had been reprogramed, as they retained a
rounded ESC-like phenotype (not shown) and expressed AP
and Oct4-puro/GFP. We observed a high number of reprog-
ramed clones, with up to a 45-fold increase (400 reprogramed
clones on average) after 24 hours of BIO culturing, and up to
a 35-fold increase (300 reprogramed clones on average) after
24 hours of Wnt3a treatment (Fig. 2B, 2C). The number of
reprogramed clones decreased after BIO treatments of 48
hours, indicating that prolonged BIO culturing reduces reprog-
raming efﬁciency, as we have previously shown [5]. These
data clearly show that time-dependent activation of the Wnt/
b-catenin pathway in ESCs allows these cells to reprogram
NSCs after their spontaneous fusion.
BIO and Wnt3a did not enhance fusion, as the same per-
centages of fused cells (Q2 fraction, double-dyed DiD/DiO
cells) were counted by FACS analysis following coculturing
of the hybrids formed in the absence and presence of BIO or
Wnt3a for the different times (Fig. 2B, 2C). Only 2% of the
Figure 1. Effects of citrinin in
BIO-treated ESCs and ES-b-cat-
enin clones. (A, B): ES cells (1
  10
4 cells) without and with
BIO treatment for the indicated
times and (C, D) ES b-catenin
clones. To evaluate the effects
of b-catenin accumulation in the
control of apoptosis, ES BIO-
treated cells and ES b-catenin
clones were then treated with
citrinin (60 lM) for 24 hours.
(A, C): Apoptosis was evaluated
using Cell Death Detection Elisa
kits (mean 6 SEM; n ¼ 3). (B,
D): Cell viability was deter-
mined by quantitation of ATP
with the Cell Titer-Glo Lumi-
nescent Cell Viability Assay
(mean 6 SEM; n ¼ 3). Fold
changes were calculated with
respect to No BIO samples. (E):
ES b-catenin clones were ana-
lyzed for proliferation potential
using the FACS-CFSE system
(mean 6 SEM; n ¼ 3). (F):
Quantitative RT-PCR analysis of
p16 and p19 transcript levels in
the ES-b-catenin clones (mean
6 SEM; n ¼ 3). Abbreviations:
BIO, 6-bromoindirubin-30-oxime;
CFSE, 5-(and 6-) carboxyﬂuores-
cein diacetate succinimidyl ester;
ES, embryonic stem; FACS, ﬂuo-
rescence activated cell sorting;
RT-PCR, real time PCR; wt, wild
type.
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ing, very few clones could be selected. In contrast, when the
Wnt/b-catenin signaling pathway was activated for a speciﬁc
time (24 hours of treatment), reprograming was strongly
enhanced, and the majority of the hybrids were then selected
and propagated as pluripotent clones with self-renewal ability.
In addition, the Wnt3a and BIO treatments did not
increase the proliferation rate of ESCs, as measured in BrdU-
positive ESCs (supporting information Fig. S2). This rules out
that the increased reprograming seen was dependent on a
Wnt3a or BIO-dependent increase in proliferation.
Interestingly, we also observed the reprograming of
hybrids when we ﬁrst allowed hybrids to form by coculturing
ESCs either with NS-Oct4-puro cells or with MEFs, and sub-
sequently activated the Wnt pathway with BIO. After 24
hours of BIO culturing of the hybrids, there was up to a 45-
fold reprograming increase for fusion between ESCs and
NSCs (650 reprogramed clones on average) and up to an
eightfold increase for fusion between ESCs and MEFs (450
reprogramed clones on average), as compared with the fusions
with untreated ESCs (supporting information Fig. S3).
To further conﬁrm these results, we sorted ES   NS
hybrids and analyzed their reprograming. The ESCs were BIO
pretreated for different times, labeled with DiD, and then
cocultured with NS-Oct4-puro cells labeled with DiO. The ef-
ﬁciency of fusion was comparable for each BIO treatment
Figure 2. Activation of the
Wnt/b-catenin pathway increases
reprograming but not spontaneous
cell fusion. (A): Schematic repre-
sentation of the experimental
plan. ESCs without and with
treatment with Wnt3a or BIO
were DiD stained and cocultured
with DiO-stained NS-Oct4-puro
cells. The cells were then divided
for FACS or reprograming deter-
minations. (B): ES cells pre-
treated with BIO. Quantiﬁcation
of FACS analysis (% total
double-labeled cells) and repre-
sentative growth plates with
quantiﬁcation of reprograming ef-
ﬁciency (fold-increase in colony
number) of the cocultured cells
(mean 6 SEM; n ¼ 3). (C):
Quantiﬁcation of FACS analysis
and reprograming efﬁciency, with
representative growth plates,
when ES cells were preatreated
with Wnt3a (mean 6 SEM; n ¼
3). Abbreviations: BIO, 6-bro-
moindirubin-30-oxime; ES, embry-
onic stem; FACS, ﬂuorescence
activated cell sorting; NS, neural
stem.
1944 Spontaneous Cell Fusion-Mediated ReprogramingFigure 3. Analysis of reprograming, fusion efﬁciency, and apoptosis of FACS-sorted hybrids. FACS analysis and reprograming efﬁciency, and
their quantiﬁcation for spontaneous fusion of BIO-pretreated ESCs (DiD labeled) with NS-Oct4-puro cells (DiO labeled). (A): The cells were
cocultured (1   10
7 cells/plate) for 4 hours (2 hours with NS medium, plus 2 hours with ES medium), trypsinized, and the hybrids were analyzed
by FACS, as % double-labeled cells (histogram; mean 6 SEM; n ¼ 4), with representative FACS analyses also shown. (B): Eighty thousand sin-
gle-labeled (green) or double-labeled (redþgreen) FACS-sorted cells were replated in p100 plates. The clones were puromycin selected, stained
for the expression of alkaline phosphatase, and counted. Quantiﬁcation of the fold change increases in the reprogramed colonies is also shown
(mean 6 SEM; n ¼ 4), along with representative FACS analysis and growth plates. (C): 1   10
4 sorted ESCs and NSCs as well as 1   10
4
sorted cell fusion hybrids were plated and apoptosis was evaluated using Cell Death Detection Elisa kits 48 hours after sorting (mean 6 SEM;
n ¼ 3). Fold changes were calculated with respect to No BIO cell fusion hybrids. (D): ES cells (1   10
4 cells) were treated with citrinin (60
lM) and with or without z-VAD for 24 hours (Left panel). Apoptosis was evaluated using Cell Death Detection Elisa kits (mean 6 SEM; n ¼
3). Quantiﬁcation of reprograming efﬁciency (fold-increase in colony number) of the cocultured cells between untreated or 24 hours-BIO-treated
ES cells with NS cells (right panel). After that, cocultured cells were trypsinized, plated, and treated or untreated for 36 hours with z-VAD (20
lM; mean 6 SEM; n ¼ 3). Abbreviations: BIO, 6-bromoindirubin-30-oxime; ES, embryonic stem; FITC, ﬂuorescein isothiocyanate; NS, neural
stem; wt, wild type; z-VAD, carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]- ﬂuoromethylketone.
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(Fig. 3A). However, a high number of reprogramed clones
(up to 25-fold reprograming) was selected only when we
plated the DiD/DiO-positive sorted hybrids derived from the
fusion of NSCs with 24-hour-BIO pretreated ESCs (Fig. 3B).
This again conﬁrms that spontaneous fusion can occur,
although with low efﬁciency; however, the hybrids undergo
reprograming and proliferation only after time-dependent acti-
vation of Wnt signaling.
To show that the hybrids that do not undergo reprogram-
ing after cell fusion embark into apoptosis, we analyzed the
sorted ES   NS hybrids for their apoptotic phenotype. In all,
10,000 fused cells (DiD/DiO positive) were sorted for each of
the time points. After the sorting, the hybrids were plated and
harvested 48 hours later. Here, we observed that hybrids
derived from 12-hour- and 48-hour-treated ESCs or from
untreated ESCs cocultured with NSCs showed a greater apo-
ptotic phenotype as compared with hybrids derived from the
24-hour-BIO-treated ESCs cocultured with NSCs (Fig. 3C),
which is the point that shows more reprograming. As control,
we also analyzed apoptosis of ES- or NS-sorted cells. As
expected, sorted cell fusion hybrids showed a greater apopto-
tic phenotype when compared with single-sorted cells (Fig.
3C). This result clearly shows that hybrids heading into
reprograming embark into apoptosis with low efﬁciency.
Next, to determine whether by blocking apoptosis, we can
isolate a greater number of reprogramed clones, we used z-
VAD, which is a general inhibitor of the activation of the ap-
optosis program [22, 23]. Two increasing doses of z-VAD
efﬁciently blocked citrinin-induced apoptosis in ESCs (Fig.
3D). Then, NS-Oct4-puro cells were cocultured with untreated
ESCs or with 24-hour-BIO-treated ESCs, and the reprogramed
hybrids were selected after being cultured with z-VAD for 36
hours. Interestingly, a slight increase in the number of reprog-
ramed clones was seen from the untreated ES   NS hybrids
when the apoptosis inhibitor was added. In contrast, as
expected, the reprograming efﬁciency was comparable in the
presence or absence of z-VAD after the coculture of 24-hour-
BIO-treated ESCs with NSCs, as these hybrids do not enter
into apoptosis (Fig. 3D). These data show that a block of the
apoptosis program can increase the reprograming of NSCs af-
ter spontaneous fusion; however, the efﬁciency of this process
is very poor if the Wnt/b-catenin signaling pathway is not
previously activated in the ESCs.
The Reprograming of Spontaneously Formed
Hybrids is Dependent on b-Catenin Accumulation
up to a Speciﬁc Threshold in ESCs
To further demonstrate that a ﬁxed level of b-catenin is im-
portant for the reprograming of somatic cells, the b-catenin-
expressing ES clones were cocultured with NS-Oct4-puro
cells. Before coculturing, ES-b-catenin clones were labeled
with DiD and NSCs with DiO. Then 80% of the cells were
analyzed by FACS and 20% were plated to select reprog-
ramed clones with puromycin. ESCs expressing low (the E1
clone), intermediate (the a-8 clone), and high (the C2 clone)
levels of b-catenin fused with comparable efﬁciency (about
2%); however, a high number of reprogramed, AP-positive
cells (750 reprogramed clones on average) were generated
Figure 4. Low levels of stabi-
lized b-catenin induce reprog-
raming of NS cells through
spontaneous cell fusion. (A):
Quantiﬁcation of FACS analysis
(% total double-labeled cells)
and representative growth plates
with quantiﬁcation of reprog-
raming efﬁciency (fold-increase
in colony number) of the cocul-
tured cells (mean 6 SEM; n ¼
3), for wild-type ESCs (E14),
ES-b-catenin clones (E1, a-8,
C2) with NS-Oct4-puro cells
(mean 6 SEM; n ¼ 3). (B): 1
  10
4 sorted cell fusion hybrids
between wild-type ESCs, ES-b-
catenin clones (E1, a-8, C2)
with NS-Oct4-puro cells were
plated and apoptosis was eval-
uated using Cell Death Detec-
tion Elisa kits 48 hours after
sorting (mean 6 SEM; n ¼ 3).
Fold changes were calculated
with respect to wild-type ESC  
neural stem cell hybrids. Abbre-
viations: ES, embryonic stem;
FACS, ﬂuorescence activated
cell sorting; FITC, ﬂuorescein
isothiocyanate.
1946 Spontaneous Cell Fusion-Mediated Reprogramingfrom only the hybrids spontaneously formed between the E1
clone and NSCs (Fig. 4A). These results demonstrate that
only ESCs expressing low amounts of b-catenin can repro-
gram hybrids that they have spontaneously formed with
NSCs.
We then investigated whether hybrids formed between the
ES-b-catenin clones and NSCs underwent apoptosis. Interest-
ingly, the FACS-sorted E1   NS hybrids showed much lower
levels of apoptosis, with respect to the untreated ES   NS
hybrids. This further conﬁrms that these hybrids that undergo
reprograming do not enter into apoptosis. However, we
observed low levels of apoptosis even in the a-8   NS and
C2   NS hybrids, which did not generate reprogramed colo-
nies (Fig. 4B). This was probably due to the high level of
p16
Ink4a and p19
Arf in these cells (Fig. 1F), which would force
them to arrest in a G0-senescent state. These data further con-
ﬁrm that b-catenin does not retain an antiapoptotic effect, as
hybrids formed between ESCs expressing high levels of b-cat-
enin and NSCs did not enter into apoptosis.
c-Myc is a target of b-catenin [24], and it can enhance
direct reprograming when overexpressed in somatic cells
along with Oct4, Klf4, and Sox2 [25]. Furthermore, c-Myc
controls the cell cycle and apoptosis [26–28]. Thus, c-Myc is
a good candidate as a downstream target of b-catenin in the
enhancement of reprograming. We previously demonstrated
that c-Myc was not transcriptionally activated in ESCs treated
for different times with BIO [5], and also others have
excluded its role in direct reprograming experiments when
MEFs were transduced with Oct4, Sox2, and Klf4 and
cultured in the presence of Wnt3a [19]. However, to
further conﬁrm these results, we have analyzed the level of
the c-Myc protein and of phosphorylated c-Myc in ESCs
treated for 12–48 hours with BIO and in b-catenin clones.
The levels of c-Myc and of phosphorylated c-Myc were com-
parable in untreated ESCs, in all of the treated ESCs, and in
all of the b-catenin clones. An increase in total c-Myc and a
decrease in phosphorylated c-Myc were instead seen in
GSK3 /  ESCs, as expected [29] (supporting information
Fig. S4). These data rule out a role for c-Myc as a b-catenin-
dependent reprograming factor.
The reprogramed phenotype of the AP-positive and puro-
mycin-resistant clones was conﬁrmed by performing in vitro
and in vivo differentiation studies. The clones were tetraploids
(supporting information Fig. S5A) and expressed GFP even
after several passages (supporting information Fig. S5B). In
addition, they expressed stem cell markers, such as Oct4,
Nanog, and Rex1, but silenced the neural-speciﬁc markers Blp
and Olig2 (supporting information Fig. S5C). CpG islands
were demethylated in the promoter regions of Oct4 and
Nanog of the reprogramed clones, which showed a methyla-
tion proﬁle similar to the ESCs (supporting information Fig.
S5D). Embryoid bodies and beating cardiomyocytes were
formed with similar timing and efﬁciency by both reprog-
ramed clones and ESCs; likewise for the expression of
markers for mesoderm (Brachyury), endoderm (AFP), and
cardiac muscle (Nkx2.5) (supporting information Fig. S5E, F).
We also observed that reprogramed clones differentiated into
several tissue types in vivo (e.g., epidermis, gut-like epithe-
lium, neural tissue, muscle, cartilage) on injection in the pos-
terior legs of SCID mice, (supporting information Fig. S5G).
All of these data demonstrate that the selected reprogramed
clones were pluripotent, as they differentiated in vitro and in
vivo.
DISCUSSION
In this study, we have demonstrated that spontaneous fusion
can occur simply by coculturing ESCs with NSCs. This is a
very inefﬁcient process in vitro. Indeed, we have shown that
the spontaneously formed hybrids embark into apoptosis, and
therefore cannot be selected. In contrast, when the Wnt sig-
naling pathway is activated in ESCs and leads to a ﬁxed
amount of b-catenin accumulation in the nucleus, then the
spontaneous hybrids can undergo reprograming and be
selected with high efﬁciency. ESCs expressing whatever
amount of b-catenin can fuse, but normally the fate of the
resulting hybrids is to undergo apoptosis, unless low levels of
nuclear b-catenin allow them to undergo reprograming instead
Figure 5. Spontaneous-fusion-mediated cell reprograming is controlled by b-catenin levels in ESCs and not by their proliferation. Wild-type
ESCs and ES clones expressing low and high b-catenin levels fuse with Neural stem cells (NSCs) spontaneously with the same low efﬁciency.
Only the hybrids formed by NSCs fused with Wnt3a-/BIO-treated ESCs or the E1 b-catenin clone become reprogramed and can be selected with
high efﬁciency. In contrast, hybrids formed by NSCs fused with wild-type ESCs enter into apoptosis-mediated cell death. Interestingly, the
hybrids formed by NSCs fused with a-8 and C2 clones, which express high levels of b-catenin, neither become reprogramed nor enter into apo-
ptosis or proliferate. This is likely due to the high levels of p16
Ink4a and p19
Arf, see main text for details. Interestingly, b-catenin levels in ESCs
modulate their ability to proliferate; however, ESC proliferation does not modulate cell fusion-mediated reprograming efﬁciency. Abbreviations:
BIO, 6-bromoindirubin-30-oxime; ES, embryonic stem; NS, neural stem.
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www.StemCells.com(see scheme in Fig. 5). This is not merely due to a Wnt-medi-
ated survival effect, indeed, b-catenin does not protect ESCs
from apoptosis (Fig. 1), and inhibition of the apoptotic path-
way does not greatly increase the efﬁciency of spontaneous
fusion-mediated reprograming (Fig. 3D). These observations
indicate that b-catenin increases the reprograming of the
hybrid cells, and as a result, the hybrids do not enter into the
apoptotic pathway.
Spontaneously formed hybrids enter into apoptosis to
avoid catastrophic consequences. This might well be a safety
control mechanism that blocks the occurrence of aneuploidy
and of genomic instability that would lead to tumor develop-
ment. Indeed, increased resistance to apoptosis of cancer stem
cells has been associated with fusion events. Spontaneous sta-
ble hybrids formed after fusions of breast cancer stem cells
with breast cancer cells showed increased expression of ATP-
binding cassette (ABC) multidrug resistance transporters and
of antiapoptotic molecules [30]. On the other hand, during
normal tissue homeostasis, the apoptotic pathway might lead
to removal of detrimental fusion events. Here, we show that
the hybrids can also face a different developmental fate:
reprograming and survival from the death mediated by
apoptosis.
Wnt is an important pathway that can induce cell prolifer-
ation and tumorigenesis, which is mainly due to Wnt-depend-
ent expression of c-myc and cyclin D1 [31]. We and others
have shown that neither of the genes for c-myc or cyclin D1
are activated when b-catenin accumulates in ESC nuclei [5,
32]. On the other hand, the proliferative state of the fusing
ESCs might also have a function in modulating reprograming
efﬁciency after spontaneous fusion. Here, we have shown that
low levels of b-catenin (Wnt/BIO-treated cells or the E1
clone) in ESCs have no effect for increasing proliferation
compared with untreated ESCs. However, if b-catenin levels
are increased (as in the case of the a-8 and C2 clones), a
strong reduction in cell proliferation is seen (Fig. 5). This
dual effect of Wnt signaling in proliferation has already been
described in other systems. Interestingly, one study revealed
that low levels of Wnt signaling stimulate human mesenchy-
mal stem cell proliferation, while high levels have an inhibi-
tory effect [33]. Moreover, the overexpression of b-catenin in
neuroblastoma cells has been shown to result in an important
reduction in proliferation [34].
Interestingly, we found that the low-proliferating a-8 and
C2 clones show a reduced ability to reprogram somatic cells,
even if they can spontaneously fuse with the same efﬁciency
as the E1 clone. This latter clone, in contrast, retained very
high fusion-mediated reprograming activity (Fig. 5). This sug-
gests that high levels of b-catenin can induce the expression
of some genes that might block reprograming. Of note, we
observed that a-8 and C2 clones express high levels of the
cell cycle regulators p16
Ink4a and p19
Arf, which have already
been shown to inhibit reprograming [35–40].
Thus, it appears that the levels of b-catenin can modulate
proliferation, although this is not the main mechanism
enhancing reprograming. Some b-catenin target genes are
expressed only when the level of b-catenin reaches a speciﬁc
threshold; these should be important factors in the reprogram-
ing of somatic cells.
On the other hand, the anti-proliferative effect due to the
increased level of the tumor suppressor genes p16
Ink4a and
p19
Arf can also have antiapoptotic functions. In fact, it is well
know that oncogenes promoting cell cycle progression also
sensitize cells to express proapoptotic factors [41]. For this
reason, the hybrids formed by NSCs and a-8 and C2 clones
did not embark into apoptosis even if they were not
reprogramed.
Fusion of ESCs and somatic cells produces reprogramed
hybrid cells when there is b-catenin accumulation or Nanog
overexpression [5, 21, 42]. However, we showed previously
that in cell fusion-mediated reprograming where both Nanog
were overexpressed and Wnt signaling was activated, the
reprograming of somatic cells was very high, but the two
pathways remained distinct. Nanog-mediated reprograming
was not dependent on activation of the Wnt/b-catenin path-
way. Furthermore, Nanog was not a b-catenin-dependent tar-
get gene [42].
In conclusion, if ESCs fuse spontaneously, this might per-
haps also hold true for adult stem cells that might fuse with
somatic cells to eventually control differentiation of the fusing
partners. Thus, cell-cell fusion also appears to represent a cell
fate and differentiation mechanism that if deregulated, might
become a mechanism for tumor development.
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